Antimicrobial resistance and management of invasive Salmonella disease

Vaccine

Volumn 33, Issue S3, 2015, Pages C21-C29

  Kariuki, Samuel ^a,b   Gordon, Melita A ^c,d   Feasey, Nicholas ^d,e   Parry, Christopher M ^f,g  

^a KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^b WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

^d MALAWI LIVERPOOL WELLCOME TRUST CLINICAL RESEARCH PROGRAMME   (Malawi)

^e LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^f LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^g NAGASAKI UNIVERSITY   (Japan)

Author keywords

Antimicrobial resistant; Epidemiology; Invasive Salmonella; Non typhoidal salmonella; Typhoid

Indexed keywords

ANTIINFECTIVE AGENT; SALMONELLOSIS VACCINE; TYPHOID VACCINE; QUINOLONE DERIVATIVE; TYPHOID PARATYPHOID VACCINE;

ANTIBIOTIC RESISTANCE; BACTERIAL STRAIN; DEVELOPING COUNTRY; HUMAN; INVASIVE SALMONELLA INFECTION; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SALMONELLA ENTERICA SEROVAR ENTERITIDIS; SALMONELLA ENTERICA SEROVAR TYPHIMURIUM; SALMONELLOSIS; TYPHOID FEVER; ADOLESCENT; AFRICA; ASIA; CHILD; DISEASE MANAGEMENT; DRUG EFFECTS; INFANT; MICROBIOLOGY; PRESCHOOL CHILD; PREVALENCE; SALMONELLA ENTERICA SEROVAR PARATYPHI A; SALMONELLA ENTERICA SEROVAR TYPHI; SALMONELLA INFECTIONS; STATISTICS AND NUMERICAL DATA;

ADOLESCENT; AFRICA; ANTI-BACTERIAL AGENTS; ASIA; CEPHALOSPORIN RESISTANCE; CHILD; CHILD, PRESCHOOL; DEVELOPING COUNTRIES; DISEASE MANAGEMENT; DRUG RESISTANCE, BACTERIAL; FLUOROQUINOLONES; HUMANS; INFANT; PREVALENCE; SALMONELLA INFECTIONS; SALMONELLA PARATYPHI A; SALMONELLA TYPHI; TYPHOID FEVER; TYPHOID-PARATYPHOID VACCINES;

EID: 84930822190     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2015.03.102     Document Type: Review

References (102)

1. Reddy E.A., Shaw A.V., Crump J.A. Community-acquired bloodstream infections in Africa: a systematic review and meta-analysis. Lancet Infect Dis 2010, 10:417-432.
2. Berkley J., Mwangi I., Griffiths K., Mithwani S., English M., Newton C. Assessment of severe malnutrition among hospitalized children in rural Kenya. J Am Med Assoc 2005, 294:591-597.
3. Kariuki S., Revathi G., Kariuki N., Kiiru J., Mwituria J., Hart C.A. Characterisation of community acquired non-typhoidal Salmonella from bacteraemia and diarrhoeal infections in children admitted to hospital in Nairobi, Kenya. BMC Microbiol 2006, 10:1-10.
4. Gordon M.A., Graham S.M., Walsh A.L., Wilson L., Phiri A., Molyneux E., et al. Epidemics of invasive Salmonella enterica serovar enteritidis and S. enterica Serovar typhimurium infection associated with multidrug resistance among adults and children in Malawi. Clin Infect Dis 2008, 46:963-969.
5. Varma J.K., Molbak K., Barrett T.J., Beebe J.L., Jones T.F., Rabatsky-Ehr T., et al. Antimicrobial-resistant nontyphoidal Salmonella is associated with excess bloodstream infections and hospitalizations. J Infect Dis 2005, 191:554-561.
6. Crump J.A., Luby S.P., Mintz E.D. The global burden of typhoid fever. Bull World Health Organ 2004, 346-353.
7. Wain J., Hendriksen R.S., Mikoleit M.L., Keddy K.H., Ochiai R.L. Typhoid fever. Lancet 2015, 385(9973):1136-1145.
8. Mogasale V., Maskery B., Ochiai R.L., Lee J.S., Mogasale V.V., Ramani E., et al. Burden of typhoid fever in low-income and middle-income countries: a systematic, literature-based update with risk-factor adjustment. Lancet Glob Health 2014, 2:e570-e580.
9. Gaind R., Paglietti B., Murgia M., Dawar R., Uzzau S., Cappuccinelli P., et al. Molecular characterization of ciprofloxacin-resistant Salmonella enterica serovar Typhi and Paratyphi A causing enteric fever in India. J Antimicrob Chemother 2006, 58:1139-1144.
10. Breiman R.F., Cosmas L., Njuguna H., Audi A., Olack B., Ochieng J.B., et al. Population-based incidence of typhoid fever in an urban informal settlement and a rural area in Kenya: implications for typhoid vaccine use in Africa. PLoS ONE 2012, 7.
11. Parry C.M., Thomas S., Aspinall E.J., Cooke R.P.D., Rogerson S.J., Harries A.D., et al. A retrospective study of secondary bacteraemia in hospitalised adults with community acquired non-typhoidal Salmonella gastroenteritis. BMC Infect Dis 2013, 13:1.
12. Majowicz S.E., Musto J., Scallan E., Angulo F.J., Kirk M., O'Brien S.J., et al. The global burden of nontyphoidal Salmonella gastroenteritis. Clin Infect Dis 2010, 50:882-889.
13. Murray C.J.L., Vos T., Lozano R., Naghavi M., Flaxman A.D., Michaud C., et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380:2197-2223.
14. Lozano R., Naghavi M., Foreman K., Lim S., Shibuya K., Aboyans V., et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380:2095-2128.
15. Beyene G., Nair S., Asrat D., Mengistu Y., Engers H., Wain J. Multidrug resistant Salmonella Concord is a major cause of salmonellosis in children in Ethiopia. J Infect Dev Ctries 2011, 5:23-33.
16. Bronowski C., Fookes M.C., Gilderthorp R., Ashelford K.E., Harris S.R., Phiri A., et al. Genomic characterisation of invasive non-typhoidal Salmonella enterica subspecies enterica serovar bovismorbificans isolates from Malawi. PLoS Negl Trop Dis 2013, 7.
17. Tennant S.M., Diallo S., Levy H., Livio S., Sow S.O., Tapia M., et al. Identification by PCR of non-typhoidal Salmonella enterica serovars associated with invasive infections among febrile patients in Mali. PLoS Negl Trop Dis 2010, 4:1-9.
18. Wadula J., von Gottberg A., Kilner D., de Jong G., Cohen C., Khoosal M., et al. Nosocomial outbreak of extended-spectrum beta-lactamase-producing Salmonella isangi in pediatric wards. Pediatr Infect Dis J 2006, 25:843-844.
19. Jones T.F., Ingram L.A., Cieslak P.R., Vugia D.J., Tobin-D'Angelo M., Hurd S., et al. Salmonellosis outcomes differ substantially by serotype. J Infect Dis 2008, 198:109-114.
20. Parkhill J., Dougan G., James K.D., Thomson N.R., Pickard D., Wain J., et al. Complete genome sequence of a multiple drug resistant Salmonella enterica serovar Typhi CT18. Nature 2001, 413:848-852.
21. McClelland M., Sanderson K.E., Clifton S.W., Latreille P., Porwollik S., Sabo A., et al. Comparison of genome degradation in Paratyphi A and Typhi, human-restricted serovars of Salmonella enterica that cause typhoid. Nat Genet 2004, 36:1268-1274.
22. Nuccio S.P., Bäumler A.J. Comparative analysis of Salmonella genomes identifies a metabolic network for escalating growth in the inflamed gut. MBio 2014, 5:1-8.
23. Langridge G.C., Fookes M., Connor T.R., Feltwell T., Feasey N., Parsons B.N. Patterns of genome evolution that have accompanied host adaptation in Salmonella. Proc Natl Acad Sci U S A 2014, 1-6.
24. Kingsley R.A., Msefula C.L., Thomson N.R., Kariuki S., Holt K.E., Gordon M.A., et al. Epidemic multiple drug resistant Salmonella Typhimurium causing invasive disease in sub-Saharan Africa have a distinct genotype Epidemic multiple drug resistant Salmonella Typhimurium causing invasive disease in sub-Saharan Africa have a distinct genotype. Genome Res 2009, 2279-2287.
25. Herrero-Fresno A., Wallrodt I., Leekitcharoenphon P., Olsen J.E., Aarestrup F.M., Hendriksen R.S. The role of the st313-td gene in virulence of Salmonella Typhimurium ST313. PLOS ONE 2014, 9:1-11.
26. Parsons B.N., Humphrey S., Salisbury A.M., Mikoleit J., Hinton J.C.D., Gordon M.a., et al. Invasive non-typhoidal Salmonella Typhimurium ST313 are not host-restricted and have an invasive phenotype in experimentally infected chickens. PLoS Negl Trop Dis 2013, 7:1-8.
27. Okoro C.K., Kingsley R.A., Connor T.R., Harris S.R., Parry C.M., Al-mashhadani M.N., et al. Intracontinental spread of human invasive Salmonella Typhimurium pathovariants in sub-Saharan Africa. Nat Genet 2012, 44:1215-1221.
28. Kotloff K.L., Nataro J.P., Blackwelder W.C., Nasrin D., Farag T.H., Panchalingam S., et al. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study. Lancet 2013, 382:209-222.
29. Paglietti B., Falchi G., Mason P., Chitsatso O., Nair S., Gwanzura L., et al. Diversity among human non-typhoidal salmonellae isolates from Zimbabwe. Trans R Soc Trop Med Hyg 2013, 107:487-492.
30. Feasey N.A., Archer B.N., Heyderman R.S., Sooka A., Dennis B., Gordon M.A., et al. Typhoid fever and invasive nontyphoid salmonellosis, Malawi and South Africa. Emerg Infect Dis 2010, 16:1448-1451.
31. MacLennan C.A., Gondwe E.N., Msefula C.L., Kingsley R.A., Thomson N.R., White S.A., et al. The neglected role of antibody in protection against bacteremia caused by nontyphoidal strains of Salmonella in African children. J Clin Invest 2008, 118:1553-1562.
32. Milledge J., Calis J., Graham S., Phiri A., Wilson L., Soko D., et al. Aetiology of neonatal sepsis in Blantyre, Malawi: 1996-2001. Ann Trop Paediatr 2013, 25:101-110.
33. Talbert A.W.A., Mwaniki M., Mwarumba S., Newton C.R.J.C., Berkley J.A. Invasive bacterial infections in neonates and young infants born outside hospital admitted to a rural hospital in Kenya. Pediatr Infect Dis J 2010, 29:945-949.
34. Van den Berg J.M., van Koppen E., Åhlin A., Belohradsky B.H., Bernatowska E., Corbeel L., et al. Chronic granulomatous disease: the European experience. PLoS ONE 2009, 4:1-10.
35. Sommet J., Missud F., Holvoet L., Ithier G., Lorrot M., Benkerrou M., et al. Morbidity among child travellers with sickle-cell disease visiting tropical areas: an observational study in a French tertiary care centre. Arch Dis Child 2013, 98:533-536.
36. Williams T.N., Uyoga S., Macharia A., Ndila C., Mcauley C.F., Opi D.H., et al. Bacteraemia in Kenyan children with sickle-cell anaemia: a retrospective cohort and case-control study. Lancet 2009, 374:1364-1370.
37. Scott J.A.G., Berkley J.A., Mwangi I., Ochola L., Uyoga S., MacHaria A., et al. Relation between falciparum malaria and bacteraemia in Kenyan children: a population-based, case-control study and a longitudinal study. Lancet 2011, 378:1316-1323.
38. Feasey N.A., Dougan G., Kingsley R.A., Heyderman R.S., Gordon M.A. Invasive non-typhoidal salmonella disease: an emerging and neglected tropical disease in Africa. Lancet 2012, 379:2489-2499.
39. Brent A.J., Oundo J.O., Mwangi I., Ochola L., Lowe B., Berkley J.A. Salmonella bacteremia in Kenyan children. Pediatr Infect Dis J 2006, 25:230-236.
40. Raffatellu M., Santos R.L., Verhoeven D.E., George M.D., Wilson R.P., Winter S.E., et al. Simian immunodeficiency virus-induced mucosal interleukin-17 deficiency promotes Salmonella dissemination from the gut. Nat Med 2008, 14:421-428.
41. MacLennan C.A., Gilchrist J.J., Gordon M.A., Cunningham A.F., Cobbold M., Goodall M., et al. Dysregulated humoral immunity to nontyphoidal Salmonella in HIV-infected African adults. Science 2010, 328:508-512.
42. Gordon M.A., Gordon S.B., Musaya L., Zijlstra E.E., Molyneux M.E., Read R.C. Primary macrophages from HIV-infected adults show dysregulated cytokine responses to Salmonella, but normal internalization and killing. AIDS 2007, 21:2399-2408.
43. Gordon M.A., Banda H.T., Gondwe M., Gordon S.B., Boeree M.J., Walsh A.L., et al. Non-typhoidal salmonella bacteraemia among HIV-infected Malawian adults: high mortality and frequent recrudescence. AIDS 2002, 16:1633-1641.
44. Nyirenda T.S., Gilchrist J.J., Feasey N.A., Glennie S.J., Bar-Zeev N., Gordon M.A., et al. Sequential acquisition of T-cells and antibodies to nontyphoidal Salmonella in Malawian children. J Infect Dis 2014, 56-64.
45. Gondwe E.N., Molyneux M.E., Goodall M., Graham S.M., Mastroeni P., Drayson M.T., et al. Importance of antibody and complement for oxidative burst and killing of invasive nontyphoidal Salmonella by blood cells in Africans. Proc Natl Acad Sci U S A 2010, 107:3070-3075.
46. Berkley J.A., Bejon P., Mwangi T., Gwer S., Williams T.N., Mohammed S., et al. HIV, malnutrition and invasive bacterial infection among children with severe malaria. Clin Infect Dis 2010, 49:336-343.
47. Bronzan R.N., Taylor T.E., Mwenechanya J., Tembo M., Kayira K., Bwanaisa L., et al. Bacteremia in Malawian children with severe malaria: prevalence, etiology, HIV coinfection, and outcome. J Infect Dis 2007, 195:895-904.
48. Mackenzie G., Ceesay S.J., Hill P.C., Walther M., Bojang K.a., Satoguina J., et al. A decline in the incidence of invasive non-typhoidal salmonella infection in the Gambia temporally associated with a decline in malaria infection. PLoS ONE 2010, 5. e10568 1-7.
49. Mtove G., Hendriksen I.C., Amos B., Mrema H., Mandia V., Manjurano A., et al. Treatment guided by rapid diagnostic tests for malaria in Tanzanian children: safety and alternative bacterial diagnoses. Malar J 2011, 10:290.
50. Tabu C., Breiman R.F., Ochieng B., Aura B., Cosmas L., Audi A., et al. Differing burden and epidemiology of non-typhi Salmonella bacteremia in rural and urban Kenya, 2006-2009. PLoS ONE 2012, 7:2006-2009.
51. Brunelle B.W., Bearson S.M.D., Bearson B.L. Tetracycline accelerates the temporally-regulated invasion response in specific isolates of multidrug-resistant Salmonella enterica serovar Typhimurium. BMC Microbiol 2013, 13:202.
52. Kariuki S., Dougan G. Antibacterial resistance in sub-Saharan Africa: an underestimated emergency. Ann N Y Acad Sci 2014, 1323:43-55.
53. Guerrant R.L., Hughes J.M., Lima N.L., Crane J. Diarrhea in developed and developing countries: magnitude, special settings, and etiologies. Rev Infect Dis 1990, 12:S41-S50.
54. Crump J.A., Ramadhani H.O., Morrissey A.B., Saganda W., Mwako M.S., Yang L.-Y., et al. Invasive bacterial and fungal infections among hospitalized HIV-Infected and HIV-uninfected adults and adolescents in Northern Tanzania. Clin Infect Dis 2011, 52:341-348.
55. Msefula C.L., Kingsley R.A., Gordon M.A., Molyneux E., Molyneux M.E., MacLennan C.A., et al. Genotypic homogeneity of multidrug resistant S. Typhimurium infecting distinct adult and childhood susceptibility groups in Blantyre, Malawi. PLoS ONE 2012, 7.
56. Maltha J., Guiraud I., Kaboré B., Lompo P., Ley B., Bottieau E., et al. Frequency of severe malaria and invasive bacterial infections among children admitted to a rural hospital in Burkina Faso. PLOS ONE 2014, 9:1-8.
57. Yang B., Qu D., Zhang X., Shen J., Cui S., Shi Y., et al. Prevalence and characterization of Salmonella serovars in retail meats of marketplace in Shaanxi, China. Int J Food Microbiol 2010, 141:63-72.
58. Wong M.H.Y., Yan M., Chan E.W.C., Biao K., Chen S. Emergence of clinical Salmonella enterica serovar typhimurium isolates with concurrent resistance to ciprofloxacin, ceftriaxone, and azithromycin. Antimicrob Agents Chemother 2014, 58:3752-3756.
59. Medalla F., Sjölund-Karlsson M., Shin S., Harvey E., Joyce K., Theobald L., et al. Ciprofloxacin-resistant Salmonella enterica serotype Typhi, United States, 1999-2008. Emerg Infect Dis 2011, 17:1095-1098.
60. Feasey N.A., Cain A.K., Msefula C.L., Derek P., Maaike A., Aslett M., et al. Drug resistance in Salmonella enterica ser. Typhimurium bloodstream infection, Malawi. Emerg Infect Dis 2014, 20:1957-1959.
61. Piddock L.J., Wray C., McClaren I., Wise R. Quinolone resistance in Salmonella spp: veterinary pointers. Lancet 1990, 336:125.
62. Nath G., Tikoo A., Manocha H., Tripathi A.K., Gulati A. Drug resistance in Salmonella typhi in North India with special reference to ciprofloxacin. J Antimicrob Chemother 2000, 46:149-150.
63. Menezes G.A., Khan M.A., Harish B.N., Parija S.C., Goessens W., Vidyalakshmi K., et al. Molecular characterization of antimicrobial resistance in non-typhoidal salmonellae associated with systemic manifestations from India Printed in Great Britain. J Med Microbiol 2010, 1477-1483.
64. Majtan J., Majtanova L., Majtan V. Increasing trend of resistance to nalidixic acid and emerging ceftriaxone and ciprofloxacin resistance in Salmonella enterica serovar Typhimurium in Slovakia, 2005-2009. Diagn Microbiol Infect Dis 2010, 68:86-88.
65. Ault A., Tennant S.M., Gorres J.P., Eckhaus M., Sandler N.G., Roque A., et al. Safety and tolerability of a live oral Salmonella typhimurium vaccine candidate in SIV-infected nonhuman primates. Vaccine 2013, 31:5879-5888.
66. Matsui H., Fukiya S., Kodama-Akaboshi C., Eguchi M., Yamamoto T. Mouse models for assessing the cross-protective efficacy of oral non-typhoidal Salmonella vaccine candidates harbouring in-frame deletions of the ATP-dependent protease lon and other genes. J Med Microbiol 2015, 64:295-302.
67. Crump J.A., Luby S.P., Mintz E.D. The global burden of typhoid fever. Bull World Health Organ 2004, 82:346-353.
68. Ochiai R.L., Acosta C.J., Danovaro-Holliday M.C., Baiqing D., Bhattacharya S.K., Agtini M.D., et al. A study of typhoid fever in five Asian countries: disease burden and implications for controls. Bull World Health Organ 2008, 86:260-268.
69. Mweu E., English M. Typhoid fever in children in Africa. Trop Med Int Heal 2008, 13:532-540.
70. Hendriksen R.S., Leekitcharoenphon P., Lukjancenko O., Lukwesa-Musyani C., Tambatamba B., Mwaba J., et al. Genomic signature of multi-drug resistant salmonella typhi related to a massive outbreak in Zambia during 2010-2012. J Clin Microbiol 2014, Ahead of pp.: 1-37.
71. Lutterloh E., Likaka A., Sejvar J., Manda R., Naiene J., Monroe S.S., et al. Multidrug-resistant typhoid fever with neurologic findings on the Malawi-Mozambique border. Clin Infect Dis 2012, 54:1100-1106.
72. Neil K.P., Sodha S.V., Lukwago L., O-Tipo S., Mikoleit M., Simington S.D., et al. A large outbreak of typhoid fever associated with a high rate of intestinal perforation in Kasese district, Uganda, 2008-2009. Clin Infect Dis 2012, 54:1091-1099.
73. Acharya D., Bhatta D., Malla S., Dumre S., Adhikari N., Kandel B. Salmonella enterica serovar Paratyphi A: an emerging cause of febrile illness in Nepal. Nepal Med Coll J 2011, 69-73.
74. Dong B.-Q., Yang J., Wang X.-Y., Gong J., von Seidlein L., Wang M.-L., et al. Trends and disease burden of enteric fever in Guangxi province, China, 1994-2004. Bull World Health Organ 2010, 88:689-696.
75. Gu W., Yang Z., Chen Y., Yin J., Yang J., Li C., et al. Molecular characteristics of Salmonella enterica Paratyphi A in Yunnan Province, southwest China. Infect Genet Evol 2015, 30:181-185.
76. Karkey A., Thompson C.N., Tran Vu Thieu N., Dongol S., Le Thi Phuong T., Voong Vinh P., et al. Differential epidemiology of Salmonella Typhi and Paratyphi A in Kathmandu, Nepal: a matched case control investigation in a highly endemic enteric fever setting. PLoS Negl Trop Dis 2013, 7.
77. Vlieghe E., Phe T., De Smet B., Veng C.H., Kham C., Sar D., et al. Increase in Salmonella enterica serovar paratyphi a infections in Phnom Penh, Cambodia, January 2011-August 2013. Eurosurveillance 2013, 18:2011-2014.
78. Yu F., Fan S., Fan X., Dong P., Wang X., Chen Y., et al. Analysis of characteristics of paratyphoid A in 157 Chinese inpatients between 1998 and 2009. Eur J Clin Microbiol Infect Dis 2011, 30:71-75.
79. Maskey A.P., Day J.N., Phung Q.T., Thwaites G.E., Campbell J.I., Zimmerman M., et al. Salmonella enterica serovar Paratyphi A and S. enterica serovar Typhi cause indistinguishable clinical syndromes in Kathmandu, Nepal. Clin Infect Dis 2006, 42:1247-1253.
80. Parry C.M., Hien T.T., Dougan G., White N.J., Farrar J.J. Typhoid fever. N Engl J Med 2002, 347:1770-1782.
81. Arjyal A., Basnyat B., Koirala S., Karkey A., Dongol S., Agrawaal K.K., et al. Gatifloxacin versus chloramphenicol for uncomplicated enteric fever: an open-label, randomised, controlled trial. Lancet Infect Dis 2011, 11:445-454.
82. Butler T. Treatment of typhoid fever in the 21st century: promises and shortcomings. Clin Microbiol Infect 2011, 17:959-963.
83. Wilcox M.H. Chloramphenicol and thiamphenicol. Antibiot. chemother. 2003, 279-283. Churchill Livingstone, Edinburgh. 8th ed. R. Finch, D. Greenwood, S. Norrby, R. Whitley (Eds.).
84. Holt K.E., Dolecek C., Chau T.T., Duy P.T., La T.T.P., van Minh Hoang N., et al. Temporal fluctuation of multidrug resistant Salmonella typhi haplotypes in the Mekong river delta region of Vietnam. PLoS Negl Trop Dis 2011, 5:1-10.
85. Chiou C.-S., Alam M., Kuo J.-C., Liu Y.-Y., Wang P.-J. Chromosome-mediated multidrug resistance in Salmonella enterica serovar typhi. Antimicrob Agents Chemother 2015, 59:721-723.
86. Forsythe C.T., Ernst M.E. Do fluoroquinolones commonly cause arthropathy in children?. Can J Emerg Med 2007, 9:459-462.
87. Effa E., Lassi Z., Critchley J., Garner P., Sinclair D., Olliaro P., et al. Fluoroquinolones for treating typhoid and paratyphoid fever (enteric fever). Cochrane Database Syst Rev 2011, (10):CD006083.
88. CLSI Performance standards for antimicrobial susceptibility testing; twenty-third informational supplement. M100-S23, Wayne, PA 2013, vol. 33.
89. Crump J.A., Kretsinger K., Gay K., Hoekstra R.M., Vugia D.J., Hurd S., et al. Clinical response and outcome of infection with Salmonella enterica serotype typhi with decreased susceptibility to fluoroquinolones: a United States FoodNet Multicenter Retrospective Cohort Study. Antimicrob Agents Chemother 2008, 52:1278-1284.
90. Hassing R.J., Goessens W.H.F., Mevius D.J., Van Pelt W., Mouton J.W., Verbon A., et al. Decreased ciprofloxacin susceptibility in Salmonella Typhi and Paratyphi infections in ill-returned travellers: the impact on clinical outcome and future treatment options. Eur J Clin Microbiol Infect Dis 2013, 32:1295-1301.
91. Koirala S., Basnyat B., Arjyal A., Shilpakar O., Shrestha K., Shrestha R., et al. Gatifloxacin versus ofloxacin for the treatment of uncomplicated enteric fever in Nepal: an open-label, randomized, controlled trial. PLoS Negl Trop Dis 2013, 7.
92. Parry C.M., Thompson C., Vinh H., Chinh N.T., Phuong L.T., Ho V.A., et al. Risk factors for the development of severe typhoid fever in Vietnam. BMC Infect Dis 2014, 14:1-9.
93. Kariuki S., Revathi G., Kiiru J., Mengo D.M., Mwituria J., Muyodi J., et al. Typhoid in Kenya is associated with a dominant multidrug-resistant Salmonella enterica serovar typhi haplotype that is also widespread in Southeast Asia. J Clin Microbiol 2010, 48:2171-2176.
94. Dutta S., Das S., Mitra U., Jain P., Roy I., Ganguly S.S., et al. Antimicrobial resistance, virulence profiles and molecular subtypes of Salmonella enterica Serovars typhi and paratyphi A blood isolates from kolkata, india during 2009-2013. PLOS ONE 2014, 9:1-13.
95. Hassing R.J., Goessens W.H.F., van Pelt W., Mevius D.J., Stricker B.H., Molhoek N., et al. Salmonella subtypes with increased MICs for azithromycin in travelers returned to the Netherlands. Emerg Infect Dis 2014, 20:705-708.
96. Choudhary A., Gopalakrishnan R., Nambi P.S., Ramasubramanian V., Ghafur K.A., Thirunarayan M.A. Antimicrobial susceptibility of Salmonella enterica serovars in a tertiary care hospital in southern India. Indian J Med Res 2013, 137:800-802.
97. Gautam K., Pokhrel B.M., Bhatta D.R., Shrestha C.D. Studies on extended spectrum beta lactamase (ESBL) producing salmonella isolates from clinical samples of Nepal. Nepal Med Coll J 2012, 14:204-206.
98. WHO Background document: the diagnosis, prevention and treatment of typhoid fever. Geneva 2003.
99. Cao X.T., Kneen R., Nguyen T.A., Truong D.L., White N.J., Parry C.M. A comparative study of ofloxacin and cefixime for treatment of typhoid fever in children. The Dong Nai Pediatric Center Typhoid Study Group. Pediatr Infect Dis J 1999, 18.
100. Pandit A., Arjyal A., Day J.N., Paudyal B., Dangol S., Zimmerman M.D., et al. An open randomized comparison of gatifloxacin versus cefixime for the treatment of uncomplicated enteric fever. PLoS ONE 2007, 2:1-9.
101. Ao T.T., Feasey N.A., Gordon M.A., Keddy K.H., Angulo F.J., Crump J.A. Global burden of invasive nontyphoidal Salmonella disease, 2010. Emerg Infect Dis 2015, 21(June (6)). 10.3201/eid2106.140999.
102. Kariuki S., Okoro C., Kiiru J., Njoroge S., Omuse G., Langridge G., et al. Ceftriaxone resistant Salmonella Typhimurium Sequence Type 313 from Kenyan patients is associated with blaCTX-M-15 gene on a novel IncHI2 plasmid. Antimicrob Agents Chemother 2015, pii: AAC.00078-15 [Epub ahead of print].